AFL vs GTBP · P/E 14, rev $4.12B vs $17.4M cap
Aflac Incorporated (AFL) versus GT Biopharma Inc (GTBP) — a side-by-side from cached financials, not a winner call.
Aflac Incorporated (AFL) is a insurance - life company listed on US.
GT Biopharma Inc (GTBP) is a biotechnology company listed on NASDAQ.
Latest reported AFL revenue for 2026-06-30 was $4.12B. Net income was $825.0M. Revenue was down 5.3% from 2026-03-31 to 2026-06-30. AFL currently screens at market cap $60.18B and trailing P/E 13.5.
GTBP does not have a complete income-statement cache yet.
AFL currently screens at market cap $60.18B and trailing P/E 13.5. GTBP currently screens at market cap $17.4M.
Not investment advice. Open the AFL and GTBP stock pages for the full models.
Not investment advice.